Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MRK
MRK logo

MRK

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRK News

Analyst Raises Merck Price Target to $112 After Q1 Beat

3d agoYahoo Finance

Merck Unveils Novel Oral PCSK9 Inhibitor Enlicitide

2d agoNewsfilter

Equity Markets Steady Amid Uncertainty; Quality Dividend Stocks Attract Investors

1d agoFool

Doceree Launches New System for Pharma Brand Teams

2d agoYahoo Finance

Eli Lilly's Mounjaro Becomes World's Best-Selling Drug

2d agoFool

Salesforce and Merck Collaborate on Unified Customer Platform

3d agoseekingalpha

Analysts Predict Market Returns for the Next Decade

4d agoFool

Comparative Income Outlook for Philip Morris and Altria

4d agoNASDAQ.COM

Merck Reports Strong Q1 2026 Earnings, Exceeds Expectations

6d agoYahoo Finance

Knoa Pharma Establishes New Board to Enhance Public Health Initiatives

May 01 2026Newsfilter

Analysis of URTH ETF's 52-Week Highs and Lows

May 01 2026NASDAQ.COM

Biotech Dealmaking Accelerates Ahead of Patent Cliffs

May 01 2026Newsfilter

Moderna Surpasses Q1 Revenue Estimates Driven by International Vaccine Sales

May 01 2026Newsfilter

Merck & Co., Inc. Q1 2026 Earnings Call Insights

Apr 30 2026seekingalpha

Eli Lilly Reports Strong Q1 Performance with Revenue Surge

Apr 30 2026CNBC

Mixed Earnings Reports from Multiple Companies

Apr 30 2026CNBC